Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth
in PRESS RELEASE 2021 on
Women in India are the first in the world to receive new…
0
0
-
Read more
-
-
Ferring presents new data at ESHRE 2021 supporting the use of Rekovelle® (follitropin delta) for individualized fertility treatment
in PRESS RELEASE 2021 onRead moreFerring presents new data at ESHRE 2021 supporting the use of Rekovelle®…
-
Ferring and Rebiotix Present Positive Interim Phase 3 Results from Open-Label Study of Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW)
in PRESS RELEASE 2021 onRead moreFerring and Rebiotix Present Positive Interim Phase 3 Results from Open-Label Study…
-
Ferring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Versus Placebo to Reduce Recurrence of C. difficile Infection
in PRESS RELEASE 2021 onRead moreFerring and Rebiotix Present Landmark Phase 3 Data Demonstrating Superior Efficacy of…
-
Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW) 2021
in PRESS RELEASE 2021 onRead moreFerring and Rebiotix to Present Landmark Data for Investigational Microbiota-based Live Biotherapeutic…
-
-
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
in PRESS RELEASE 2021 onRead moreFerring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive…
-
Simple Pharma acquires Testavan® and Vitaros®, two established men’s health brands, from Ferring
in STATEMENT 2021 onRead moreSimple Pharma acquires Testavan® and Vitaros®, two established men’s health brands, from…
-
Ferring Statement on Minirin® / Octostim®/ DDAVP®/ Stimate® (desmopressin) Nasal Spray
in STATEMENT 2021 onRead more